Rna Diagnostics Inc. appoints Dr. Matthew P. Goetz to Clinical Advisory Board

Rna Diagnostics Inc. announced today that Dr. Matthew P. Goetz, Consultant and Professor at Mayo Clinic, Rochester, MN has been appointed to the company’s Clinical Advisory Board (CAB).

Dr. Goetz brings a wealth of scientific knowledge and clinical trial experience in breast cancer to Rna Diagnostics. We are delighted to have him join our Clinical Advisory Board.
— Jeremy Bridge-Cook, President and CEO of Rna Diagnostics Inc.

Dr. Goetz is a clinician in the Division of Medical Oncology at Mayo Clinic in Rochester, Minnesota and a Professor of Oncology and Pharmacology at Mayo Clinic. He is chair of the Mayo Clinic Breast Cancer Research Group, Co-leader of the Mayo Clinic Women’s Cancer Program, and Co-leader of the Mayo Clinic Breast Cancer SPORE.

Read the full press release here.

Previous
Previous

Norgen Biotek Corp Launches New Portfolio for Next Generation Sequencing, including Library Preparation Kits and Full NGS Service Offering

Next
Next

Proteocyte Diagnostics: New Study Provides More Straticyte™ Support